Efficacy and safety of liposomal cytarabine in lymphoma patients with central nervous system involvement from lymphoma
✍ Scribed by Jose A. Garcia-Marco; Carlos Panizo; Eva Sanchez Garcia; Guillermo Deben; Alberto Alvarez-Larran; Eva Gonzalez Barca; Juan Manuel Sancho; Maria Jesus Penarrubia; Tomas Garcia-Cerecedo; Jose A. García-Vela
- Publisher
- John Wiley and Sons
- Year
- 2009
- Tongue
- English
- Weight
- 118 KB
- Volume
- 115
- Category
- Article
- ISSN
- 0008-543X
No coin nor oath required. For personal study only.
📜 SIMILAR VOLUMES
## Abstract ## BACKGROUND Venous thromboembolism (VTE) is a frequent complication in patients with cancer throughout the course of the disease. Patients with brain tumors are at particularly high risk for VTE, and several risk factors were found in patients with malignant glioma. To the authors' k
Records of 105 patients with central nervous system (CNS) lymphoma were analyzed in order to better define the incidence, setting, and management of CNS lymphoma and the role for CNS prophylaxis. Survival was best for patients under 30 years of age treated with whole-brain irradiation and intratheca
## Abstract ## BACKGROUND. The incidence of primary central nervous system lymphoma (PCNSL) has increased in recent decades and is highest in people aged ≥65 years. Radiotherapy (XRT) and systemic chemotherapy (CTX), alone or in combination, are reported to extend survival, but treatment‐related t